Lv1
30 积分 2023-12-12 加入
Ibrutinib plus venetoclax in relapsed or refractory mantle cell lymphoma (SYMPATICO): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
2天前
已完结
Thyroid receptor β: A promising target for developing novel anti-androgenetic alopecia drugs
6个月前
已完结
Canonical Chinese medicine formula Danzhi-Xiaoyao-San for treating depression: A systematic review and meta-analysis
1年前
已完结
Native Spleen Preservation During Visceral Transplantation Inhibits Graft-Versus-Host-Disease Development
1年前
已完结
皖公网安备34019202002308
